A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV
Public ClinicalTrials.gov record NCT05630885. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Limited-Center, Prospective, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV
Study identification
- NCT ID
- NCT05630885
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Interventions
- CVC 150 mg Drug
- CVC 300 mg Drug
- Placebo for CVC 150 mg Other
- Placebo for CVC 300 mg Other
Drug · Other
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 29, 2023
- Primary completion
- Jun 18, 2024
- Completion
- Jun 18, 2024
- Last update posted
- Jul 15, 2025
2023 – 2024
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, Los Angeles CARE Center CRS (Site # 601) | Los Angeles | California | 90035 | — |
| UCSD Antiviral Research Center CRS (Site # 701) | San Diego | California | 92103 | — |
| UCSF HIV/AIDS CRS (Site # 801) | San Francisco | California | 94110 | — |
| Harbor University of California Los Angeles Center CRS (Site # 603) | Torrance | California | 90502 | — |
| Northwestern University CRS (Site # 2701) | Chicago | Illinois | 60611 | — |
| Massachusetts General Hospital CRS (MGH CRS) (Site # 101) | Boston | Massachusetts | 02114 | — |
| Brigham and Women's Hospital Therapeutics (BWH TCRS) CRS (Site # 107) | Boston | Massachusetts | 02115 | — |
| Washington University Therapeutics (WT) CRS (Site # 2101) | St Louis | Missouri | 63110-1010 | — |
| Weill Cornell Chelsea CRS (Site # 7804) | New York | New York | 10010 | — |
| Weill Cornell Uptown CRS (Site # 7803) | New York | New York | 10065 | — |
| University of Rochester Adult HIV Therapeutic Strategies Network CRS (Site # 31787) | Rochester | New York | 14642 | — |
| Chapel Hill CRS (Site # 3201) | Chapel Hill | North Carolina | 27599-7215 | — |
| Cincinnati CRS (Site # 2401) | Cincinnati | Ohio | 45267-0405 | — |
| Case CRS (Site # 2501) | Cleveland | Ohio | 44106 | — |
| Ohio State University CRS (Site # 2301) | Columbus | Ohio | 43210-1282 | — |
| University of Pittsburgh CRS (Site # 1001) | Pittsburgh | Pennsylvania | 15213 | — |
| Vanderbilt Therapeutics (VT) CRS (Site # 3652) | Nashville | Tennessee | 37204 | — |
| Houston AIDS Research Team CRS (Site # 31473) | Houston | Texas | 77030 | — |
| University of Washington Positive Research CRS (Site # 1401) | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05630885, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 15, 2025 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05630885 live on ClinicalTrials.gov.